MGC Pharmaceuticals has received permission to import psilocybin into Slovenia.
Kernel has published results from its Cybin-sponsored neuroimaging study which show the ability of Kernel’s Flow1 system to capture and analyse brain changes induced by psychedelics.
A low-cost version of ketamine has shown promising results in its treatment of resistant depression in a double-blind trial.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
The Psychedelic Access and Research Alliance (PAREA) has released a position statement calling on the EU to harness psychedelics in a bid to create innovation in...
A donation of $1.5 million has been gifted to the UC San Diego Psychedelics and Health Research Initiative to research DMT by philanthropist Eugene Jhong.
Until now, it has been commonly thought that selective serotonin reuptake inhibitors (SSRIs) could interfere with the therapeutic potential of psilocybin treatment.
A group of experts has published a paper in the American Journal of Psychiatry examining the definition of “psychedelic-assisted psychotherapy” using psilocybin.
In what marks a positive development for patient access to psychedelic therapies in the US, the American Medical Association has released the language of its first-ever...
Psychedelic Medicine Investment Fund Negev Capital is aiming to innovate mental healthcare in Europe by providing funding to companies on the cutting edge of psychedelic research.
